Recombinant OSMR (Vixarelimab Biosimilar) antibody

Catalog No. ABIN7491013

This anti-OSMR (Vixarelimab Biosimilar) antibody is a Human Monoclonal antibody detecting OSMR (Vixarelimab Biosimilar) in FACS. Suitable for Human.

Quick Overview for Recombinant OSMR (Vixarelimab Biosimilar) antibody (ABIN7491013)

Target: OSMR (Vixarelimab Biosimilar)

Antibody Type: Recombinant Antibody

Reactivity: Human

Host: Human

Clonality: Monoclonal

Conjugate: This OSMR (Vixarelimab Biosimilar) antibody is un-conjugated

Application: Flow Cytometry (FACS)

Grade: Research Grade

Product Details anti-OSMR (Vixarelimab Biosimilar) Antibody

Purpose: Anti-OSMR (vixarelimab biosimilar) mAb

Characteristics: KPL-716

Purification: Purified from cell culture supernatant by affinity chromatography

Isotype: IgG4 lambda

Application Details

Application Notes: Flow Cyt 1:100

Comment:

Research grade biosimilar. Not for use in therapeutic or diagnostic procedures for humans or animals.

Restrictions: For Research Use only

Handling

Format: Lyophilized

Reconstitution: Reconstitute with deionized water

Buffer: Lyophilized from sterile PBS, pH 7.4. Normally 5 % - 8 % trehalose is added as protectants before lyophilization.

Storage: -20 °C,-80 °C

Storage Comment: Store at -20°C to -80°C for 12 months in lyophilized form. After reconstitution, if not intended for use within a month, aliquot and store at -80°C (Avoid repeated freezing and thawing). Lyophilized proteins are shipped at ambient temperature.

Expiry Date: 12 months

Target Details for OSMR (Vixarelimab Biosimilar)

Target: OSMR (Vixarelimab Biosimilar)

Background: Synonyms: IL-31 receptor subunit beta, IL-31R subunit beta, IL-31R-beta, IL-31RB

UniProt: Q99650